Antithymocyte Globulin (ATG)

DRUG9 trials

Conditions

Graft Versus Host DiseaseHematologic MalignanciesHematological DiseaseHematopoietic Stem Cell Transplantation (HSCT)LeukemiaLeukemia, Myeloid, Acute(AML)Myelodysplastic SyndromeSevere Aplastic Anemia

Phase 1

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

Active, not recruitingNCT04098393

Memorial Sloan Kettering Cancer CenterHematologic Malignancies

Start: 2019-09-18End: 2026-09-01Target: 39Updated: 2026-06-30

Phase 2

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

NCT00466843

Office of Rare Diseases (ORD)Myelodysplastic Syndrome

Start: 2007-04-30End: 2010-02-28Target: 54Updated: 2009-06-02

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

TerminatedNCT00499889

M.D. Anderson Cancer CenterLeukemia

Start: 2003-02-28End: 2009-11-30Updated: 2012-04-23

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

TerminatedNCT00720629

H. Lee Moffitt Cancer Center and Research InstituteGraft Versus Host Disease

Start: 2007-12-31End: 2013-12-31Updated: 2014-07-18

Cord Blood Transplantation for Patients With Cancer

TerminatedNCT01359254

University of ChicagoHematological Disease

Start: 2010-04-30End: 2012-06-30Updated: 2015-04-30

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

CompletedNCT02918292

Medical College of WisconsinSevere Aplastic Anemia

Start: 2017-07-03End: 2021-08-17Updated: 2026-03-31

BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

Active, not recruitingNCT05156710

SanofiTransplant Rejection

Start: 2022-06-09End: 2026-10-20Updated: 2026-08-21

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

RecruitingNCT07216391

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Type 1 Diabetes Mellitus

Start: 2026-07-29End: 2030-05-30Target: 60Updated: 2026-09-09

Unknown Phase

A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients

Not yet recruitingNCT07762508

The First Affiliated Hospital of Soochow UniversityHematopoietic Stem Cell Transplantation (HSCT), Leukemia, Myeloid, Acute(AML)

Start: 2026-08-01End: 2029-07-01Target: 42Updated: 2026-08-19

Related Papers

Trial in Progress: Cureaa - a Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) #2207

Blood2024-11-05

Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.

2022-07-2754 citations

A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction

Haematologica2014-01-3141 citations